<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; Allergy</title>
	<atom:link href="http://www.canadiannetmall.com/blog/category/allergy/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.canadiannetmall.com/blog</link>
	<description></description>
	<lastBuildDate>Sat, 07 May 2011 13:51:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Limiting Access to Antihistamines in Allergic Patients</title>
		<link>http://www.canadiannetmall.com/blog/limiting-access-to-antihistamines-in-allergic-patients/</link>
		<comments>http://www.canadiannetmall.com/blog/limiting-access-to-antihistamines-in-allergic-patients/#comments</comments>
		<pubDate>Fri, 04 Feb 2011 07:15:05 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Allergy]]></category>
		<category><![CDATA[Allergic Patients]]></category>
		<category><![CDATA[Antihistamines]]></category>
		<category><![CDATA[Limiting Access]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4447</guid>
		<description><![CDATA[In response to the availability of one nonsedating antihistamine as an over-the-counter drug, state Medicaid and several large health insurers are considering whether to end prescription drug coverage for all nonsedating antihista-mines. These policies, by their design, would diminish access to recognized standards of treatment for millions of patients with allergic diseases. Professional experience suggests [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/limiting-access-to-antihistamines-in-allergic-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Promethazine in Children</title>
		<link>http://www.canadiannetmall.com/blog/promethazine-in-children/</link>
		<comments>http://www.canadiannetmall.com/blog/promethazine-in-children/#comments</comments>
		<pubDate>Mon, 09 Aug 2010 09:42:21 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Allergy]]></category>
		<category><![CDATA[Promethazine]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=3626</guid>
		<description><![CDATA[The FDA has notified health care professionals and patients that serious and sometimes fatal breathing problems have occurred in children younger than two years of age who were given the anti-histamine agent promethazine HCl (e.g., Phenergan medication, Wyeth). Parents and care-givers should obtain a doctor&#8217;s advice about giving promethazine in any form to children age [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/promethazine-in-children/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Layering  May Benefit Deep Wounds</title>
		<link>http://www.canadiannetmall.com/blog/layering-may-benefit-deep-wounds/</link>
		<comments>http://www.canadiannetmall.com/blog/layering-may-benefit-deep-wounds/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 19:07:53 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Allergy]]></category>
		<category><![CDATA[lidocaine]]></category>
		<category><![CDATA[tetracaine]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=3232</guid>
		<description><![CDATA[Topical anesthesia can eliminate the need for an anesthetic injection. &#8220;Layering,&#8221; a technique for administering topical anesthetics, has been studied mainly in children and in small wounds, but a Harvard study suggests that the practice might have a broader application. Researchers compared a sequential layered application of anesthetic ingredients with 2% lidocaine infiltration in 100 [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/layering-may-benefit-deep-wounds/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Extavia for Relapsing Multiple Sclerosis</title>
		<link>http://www.canadiannetmall.com/blog/extavia-for-relapsing-multiple-sclerosis/</link>
		<comments>http://www.canadiannetmall.com/blog/extavia-for-relapsing-multiple-sclerosis/#comments</comments>
		<pubDate>Thu, 31 Dec 2009 15:52:14 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Allergy]]></category>
		<category><![CDATA[Anti Viral]]></category>
		<category><![CDATA[Extavia]]></category>
		<category><![CDATA[Rebetol]]></category>
		<category><![CDATA[Relapsing]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2627</guid>
		<description><![CDATA[The FDA has approved Extavia (interferon beta-1b) to reduce the frequency of exacerbations in patients with relapsing forms of multiple sclerosis (MS). Developed by Novartis, Extavia is also indicated for patients who have experienced a first clinical episode of MS and who have features consistent with the disease, as shown by magnetic resonance imaging (MRI). [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/extavia-for-relapsing-multiple-sclerosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Boxed Warning For Promethazine HCl Injection</title>
		<link>http://www.canadiannetmall.com/blog/boxed-warning-for-promethazine-hcl-injection/</link>
		<comments>http://www.canadiannetmall.com/blog/boxed-warning-for-promethazine-hcl-injection/#comments</comments>
		<pubDate>Fri, 18 Dec 2009 18:46:20 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Allergy]]></category>
		<category><![CDATA[antiemetic]]></category>
		<category><![CDATA[Phenergan]]></category>
		<category><![CDATA[Promethazine]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2584</guid>
		<description><![CDATA[A black-box warning is now required for the injectable form of promethazine drug , a sedative and an antinausea/antiemetic agent. The warning highlights the risk of serious tissue injury when the drug is administered incorrectly. The prescribing information will warn that  cheap promethazine should not be injected into an artery or under the skin because [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/boxed-warning-for-promethazine-hcl-injection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

